Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses.
Immunity. 2022 Aug 11:S1074-7613(22)00350-8. doi: 10.1016/j.immuni.2022.07.015. Online ahead of print.
Immunity. 2022.
PMID: 35977542